Noradrenergic Drug Market Trends

Growth Drivers

• Growing Prevalence of Autism – On account of the growing awareness and screening of autism spectrum disorder, the market is expected to expand more in the upcoming years. According to the World Health Organization (WHO), one in 100 children globally suffers from autism.

• Rising Geriatric Population – Elderly population is more prone to dementia and the rising number of elderly populations across the globe is estimated to drive market growth. In 2020, there were more people over the age of 60 than children under five, and by 2050, it is predicted that 80% of the world's old people will live in low- and middle-income countries.

• Surging Incidences of Hypertension – According to the most recent data, more than 40% with uncontrolled hypertension have a blood pressure of 140/90 mmHg or higher.

• Increasing Diseases such as Obesity and Diabetes – It is expected that patients with obesity or diabetes are likely to be more susceptible to heart disease, diabetes, and high blood pressure, which is anticipated to drive the market growth. It was discovered that over 30 million Americans, suffered from diabetes in 2019.

Challenges

• Lack of Awareness regarding Mental Health - The increasing concern amongst individuals for the lack of knowledge about mental health is one of the major factors predicted to slow down the market growth. For instance, people may not recognize the symptoms as indicators of mental disease, therefore, they are less likely to seek professional care.
• Exorbitant Initial Expenditure
• Side Effects of Noradrenergic Drugs